Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
4670
Trial Sponsor
Clinical Trial Start Date
March 29, 2022
0Primary Completion Date
May 12, 2023
0Study Completion Date
May 12, 2023
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Other0
Intervention Name
TPOXX Placebo0
TPOXX0
Interventional Trial Phase
Phase 30
Participating Facility
Official Name
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety, Tolerability, and Pharmacokinetics of TPOXX When Administered Orally for 28 Days in Adult Subjects0
Last Updated
July 19, 2023
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Masked Party
Investigator0
Participant0
Study summary
This is a study to assess the safety, tolerability, and PK of oral TPOXX 600 mg when administered BID for 28 days in adult subjects.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
